AristaMD Adds Ascension Ventures and .406 Ventures to Investment Syndicate

AristaMD, a digital health company, has announced investments from Ascension Ventures, a strategic healthcare venture firm representing 13 of the nation´s non-for-profit health systems, and .406 Ventures, a venture capital firm investing in early stage disruptive enterprise technology and digital health companies, the company said.

These investments top off the company´s Series B funding round, which was co-led by Cigna Ventures and MemorialCare Innovation Fund, at USD 24 million. The new capital will be used to accelerate commercial growth as well as continue the expansion of its proprietary eConsult platform supporting payors and health systems across the country.

Designed by practicing physicians, AristaMD´s eConsult solution empowers PCPs to expand their scope and collaborate on patient care with a world-class panel of on-demand specialists. AristaMD significantly increases access to appropriate and timely care to improve outcomes and reduce costs.

AristaMD is focused on improving patient outcomes through more timely access to specialty care. Its eConsult platform provides a telehealth solution that empowers primary care providers with clinical workup checklists and the ability to conduct electronic consults (also known as eConsults or virtual consults) to significantly improve the patient referral process and allow greater access to timely, high-quality care. For additional information, visit

Ascension Ventures is a strategic healthcare venture firm with four funds and more than USD 800 million in capital under management. The firm was launched in 2001 by Ascension, one of the nation´s Catholic and non-profit health systems, and today invests on behalf of thirteen of the nation´s community health systems. For more information visit

.406 Ventures is a Boston-based early stage venture capital firm investing in healthcare and enterprise technology companies founded by visionary entrepreneurs. The firm was founded in 2005 and has over USD 1 billion under management across four core and two opportunity funds. Learn more at